Navigation Links
Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival

-- EORTC 18991 Phase III Study Results Presented At ASCO --

CHICAGO – June 2, 2007 – Long-term treatment with pegylated interferon alfa-2b in stage III melanoma had a significant and sustained impact on relapse-free survival (RFS), according to the results of the largest adjuvant trial ever conducted in patients with stage III melanoma. Results of the Phase III study, led by the European Organisation for the Research and Treatment of Cancer (EORTC) and supported by Schering-Plough, were presented today by Alexander Eggermont, M.D., Ph.D. at the 43rd Annual Meeting of the American Society of Clinical Oncology.

“Advanced stage melanoma remains difficult to treat and a need still exists to find treatment options,” said Alexander Eggermont, M.D., Ph.D., lead investigator and head of the department of surgical oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. “These findings demonstrate the benefit of an increased relapse-free survival (RFS) despite no difference in overall survival.”
Median RFS was 34.8 months in the pegylated interferon alfa-2b arm vs. 25.5 months in the observational arm (p-value 0.01). Median distant metastasis-free survival (DMFS) was 45.6 months in subjects receiving pegylated interferon alfa-2b therapy versus 36.1 months in observational arm (p-value 0.11).


The response to therapy appeared to be most pronounced in a subgroup of subjects with only microscopic nodal involvement (patients with positive sentinel node(s) who experienced both increased relapse-free survival (RFS) (p-value 0.02) and distant metastasis-free survival (DMFS) (p-value 0.03). This group of patients constituted
43 percent of the trial population. At present, because of the increased use of sentinel node staging , this patient population largely constitutes the majority of patients diagnosed with stage III disease.'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
3. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
4. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
5. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
6. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
7. UCB Presents Long-Term CImzia Data in Crohns Disease
8. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
11. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
Post Your Comments:
(Date:7/28/2014)... , July 28, 2014 CTI BioPharma ... it will report its second quarter 2014 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
(Date:7/25/2014)... 2014 /PRNewswire-iReach/ -- "Australia Capsule Endoscopy Systems Market Outlook ... Capsule Endoscopy Systems market. The report provides value, in ... prices (in US dollars) within market segments: ... Capsule Endoscopes , Capsule Endoscopy Data Recorders ... also provides company shares and distribution shares data for ...
(Date:7/25/2014)... 25, 2014  CVS Caremark Corporation (NYSE: ... Tuesday, August 5, 2014, at 8:30 a.m. (EDT) with ... financial results. An audio webcast of the ... Relations portion of the CVS Caremark website for all ... . This webcast will be archived and available on ...
Breaking Medicine Technology:CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... 07, 2007 /PRNewswire-FirstCall/ --,Mymetics Corporation announced today ... vaccine elicited neutralizing,IgA mucosal antibodies in a ... as a possible first line of defense,against ... by Sylvain,Fleury, Ph.D., Mymetics' Chief Scientific Officer, ...
... 7, 2007 - Dynogen,Pharmaceuticals, Inc. reported positive ... trial of DDP733 for,gastroesophageal reflux disease (GERD). ... DDP733 as a treatment for,nocturnal GERD (NGERD). ... significance over placebo on the primary endpoint ...
Cached Medicine Technology:Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 2Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 3Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 4Dynogen Reports Positive Results in Phase 1B GERD Study 2Dynogen Reports Positive Results in Phase 1B GERD Study 3Dynogen Reports Positive Results in Phase 1B GERD Study 4
(Date:7/28/2014)... July 28, 2014 A St. Jude ... adult survivors of childhood cancer more than doubled their ... by failing to follow a heart-healthy lifestyle. The results ... , Almost 32 percent of the 1,598 adult survivors ... an umbrella term for health risk factors like high ...
(Date:7/28/2014)... July 2014: ESC Congress 2014 promises to be bigger, ... Keith Fox, Chair of the Congress Programme Committee. The ... most influential cardiovascular event every year in August. Record ... this year and the congress is on track to ... , Asked why an extra hot line session ...
(Date:7/28/2014)... group of researchers in Taiwan has developed a new ... early complication of diabetes sooner, when it is more ... in clinical trials, it may pave the way for ... complication, called diabetic autonomic neuropathy, which is common among ... The condition progressively affects the autonomic nerves controlling vital ...
(Date:7/28/2014)... Brea, CA (PRWEB) July 28, 2014 ... management business process outsourcing (BPO) for Fortune 500 brands, ... 2,500 jobs across its locations in Wisconsin, California, Florida ... will be based at its Brea campus. , A ... clients, which have seasonal ramp-ups that require additional staffing ...
(Date:7/28/2014)... Brisbane, Australia (PRWEB) July 28, 2014 ... achieve a happier lifestyle can often be a struggle ... international channel, psychic and medium, Lynette Leckie-Clark provides simple ... new book “The Magic of You.” With inspiring spiritual ... thinking, you can find empowerment, confidence and motivation for ...
Breaking Medicine News(10 mins):Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 2Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 3Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 4Health News:ESC Congress 2014 focuses on innovations in cardiology 2Health News:ESC Congress 2014 focuses on innovations in cardiology 3Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Alta Resources to Fill Approximately 700 Positions in Brea 2Health News:Alta Resources to Fill Approximately 700 Positions in Brea 3Health News:Be Empowered to Achieve Happiness from New Book "The Magic of You" 2
... being fed contaminated feed is causing concern among the people. The ... years . The FDA is quick to play down the fear ... ,This concern came to light after some 38 chicken farms in ... farms fed the chicken for human consumption with the contaminated feed. ...
... C (HCV), survival has improved over time. However, for ... to a study in the issue of Liver Transplantation. ... reason for liver transplantation in the U.S., however, previous ... as well to liver transplantation. The difference has become ...
... governor, James E. McGreevy appears to be knocking on a ... the news for the right reasons. He has been ... ,Former Gov. James E. McGreevy, who was brought up as ... on Sunday at St. Bartholomew's Church in New York. He ...
... said the government is working to draft a law allowing ... of genetic disorders. ,"We are studying it from ... choice to have the abortion will be under the umbrella ... religious and social environment," Ali Shakar of the ministry of ...
... more than twice as likely to also have symptoms of ... not have migraines, according to research. ,The study involved ... screening questionnaire within 90 days after returning from one year ... the soldiers, or 60 percent, completed the questionnaire. Of those, ...
... warming, but only few act. ,The ... has two parts. One, human beings get stubbornly comfortable in ... programmed to act in its own best interests - and ... point. ,In addition, the overwhelming size and abstract ...
Cached Medicine News:Health News:Tainted Pet Food a Health Risk for Human? 2Health News:HCV Patients Survival After Liver Transplantation is Not Improving 2Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2Health News:Why Humans Fail to Act on Climate Change 2Health News:Why Humans Fail to Act on Climate Change 3
... operating and recovery room, ,The Cardiocap ... haemodynamic and airway gas monitoring for induction ... units. The Cardiocap II is available in ... haemodynamic measurements. Two of the models include ...
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
For accurately monitoring heart and breath sounds....
For accurately monitoring core temperature and heart and breath sounds....
Medicine Products: